Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.
The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital ...More >>
|There are currently no events scheduled.|
New Journal Article Highlights Mechanical Effects of Orbital Atherectomy and Rotational Atherectomy in Treating Heavily Calcified Coronary Lesions
Cardiovascular Systems Peripheral and Coronary Data Featured at EuroPCR 2015
Cardiovascular Systems Features Two-Year ORBIT II Coronary Data and Long-Term Economic Data in Late-Breaking Presentation at SCAI 2015 Scientific Sessions
Cardiovascular Systems to Feature ORBIT II Two-Year and Long-Term Economic Data in Late-Breaking Presentation at the SCAI 2015 Scientific Sessions
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.